ENDOXAN for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 21 adverse event reports in the FDA FAERS database where ENDOXAN was used for Breast cancer.
Most Reported Side Effects for ENDOXAN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 56 | 13.4% | 56 | 0 |
| No adverse event | 37 | 8.9% | 0 | 0 |
| Maternal exposure before pregnancy | 26 | 6.2% | 0 | 0 |
| Musculoskeletal disorder | 25 | 6.0% | 0 | 0 |
| Toxicity to various agents | 24 | 5.7% | 8 | 0 |
| Disease progression | 21 | 5.0% | 6 | 1 |
| Febrile neutropenia | 20 | 4.8% | 0 | 3 |
| Disease recurrence | 19 | 4.6% | 3 | 0 |
| Pneumonia | 15 | 3.6% | 3 | 1 |
| Acute graft versus host disease | 14 | 3.4% | 1 | 0 |
| Bone marrow failure | 11 | 2.6% | 3 | 3 |
| Drug ineffective | 11 | 2.6% | 6 | 1 |
| Exposure via father | 11 | 2.6% | 0 | 0 |
| Pyrexia | 11 | 2.6% | 2 | 9 |
| Breast cancer recurrent | 10 | 2.4% | 0 | 0 |
Other Indications for ENDOXAN
Breast cancer stage i (58)
Stem cell transplant (49)
Neoplasm malignant (37)
Lupus nephritis (24)
Bone marrow conditioning regimen (23)
Chronic lymphocytic leukaemia (23)
Plasma cell myeloma (21)
B-cell lymphoma (14)
Diffuse large b-cell lymphoma (14)
Temporal arteritis (12)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)